TRAIL and KILLER are expressed and induce apoptosis in the murine preimplantation embryo

Biology of Reproduction

Volumn 71, Issue 3, 2004, Pages 871-877

  Riley, Joan K ^a   Heeley, Jennifer M ^a   Wyman, Amanda H ^a   Schlichting, Elizabeth L ^a   Moley, Kelle H ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

Apoptosis; Cytokines; Early development; Embryo; Immunology

Indexed keywords

DACTINOMYCIN; DEATH RECEPTOR 5; FAS ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; BLASTOCYST; EMBRYO; MORULA; MOUSE; NICK END LABELING; NONHUMAN; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLASTOCYST; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IN SITU NICK-END LABELING; LIGANDS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

MAMMALIA; MURINAE;

EID: 4243128240     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.103.026963     Document Type: Article

References (70)

1. Baehrecke EH. How death shapes life during development. Nat Rev Mol Cell Biol 2002; 3:779-787.
2. Moley KH, Chi MM-Y, Knudson CM, Korsmeyer SJ, Mueckler MM. Hyperglycemia induces apoptosis in preimplantation embryos via cell death effector pathways. Nat Med 1998; 12:1421-1424.
3. Pampfer S, Vanderheyden I, McCracken JE, Vesela J, De Hertogh R. Increased cell death in rat blastocysts exposed to maternal diabetes in utero and to high glucose or tumor necrosis factor α in vitro. Development 1997; 124:4827-4836.
4. Moley KH. Hyperglycemia and apoptosis: mechanisms for congenital malformations and pregnancy loss in diabetic women. Trends Endocrinol Metab 2001; 12:78-82.
5. Roth W, Reed JC. Apoptosis and cancer: when BAX is TRAILing away. Nat Med 2002; 8:216-218.
6. Gupta S. Molecular signaling in death receptor and mitochondrial pathways of apoptosis. Int J Oncol 2003; 22:15-20.
7. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998; 281:1305-1308.
8. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3:673-682.
9. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996; 271:12687-12690.
10. Wu G, Burns T, Zhan Y, Alnemri E, El-Deiry W. Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor. Cancer Res 1999; 59:2770-2775.
11. MacFarlane M. TRAIL-induced signaling and apoptosis. Toxicol Lett 2003; 139:89-97.
12. Schneider P, Olson D, Tardivel A, Browning B, Lugovskoy A, Gong D, Dobles M, Hertig S, Hofmann K, Van Vlijmen H, Hsu YM, Burkly LC, Tschopp J, Zheng TS. Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Biol Chem 2003; 278:5444-5454.
13. Bodmer JL, Holler N, Reynard S, Vinciguerra P, Schneider P, Juo P, Blenis J, Tschopp J. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol 2000; 2:241-243.
14. Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, Blenis J, Krammer PH, Walczak H. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 2000; 12:599-609.
15. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 2000; 12: 611-620.
16. Brojatsch J, Naughton J, Rolls MM, Zingler K, Young JA. CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis. Cell 1996; 87:845-855.
17. Bridgham JT, Johnson AL. Avian TVB (DR5-like) death receptor expression in hen ovarian follicles. Biochem Biophys Res Commun 2002; 291:226-232.
18. Manabe M, Myoumoto A, Tajima C, Fukumoto M, Nakayama M, Uchio K, Yamaguchi M, Miyamoto H. Immunochemical characteristics of a novel cell death receptor and a decoy receptor on granulosa cells of porcine ovarian follicles. Cytotechnology 2000; 33:189-201.
19. Manabe M, Myoumoto A, Tajima C, Nakayama M, Yamaguchi M, Yamada-Uchio K, Miyamoto H. Monoclonal antibodies recognize a novel cell death receptor and a decoy receptor on granulosa cells of porcine ovarian follicles. Journal of Mammalian Ova Research 2001; 18:1-13.
20. Wada S, Manabe N, Nakayama M, Inou N, Matsui T, Miyamoto H. TRAIL-decoy receptor 1 plays inhibitory role in apoptosis of granulosa cells from pig ovarian follicles. J Vet Med Sci 2002; 64:435-439.
21. Phillips TA, Ni J, Pan G, Ruben SM, Wei YF, Pace JL, Hunt JS. TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege. J Immunol 1999; 162:6053-6059.
22. Phillips TA, Ni J, Hunt JS. Death-inducing tumor necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines. Placenta 2001; 22:663-672.
23. Moley KH, Chi M, Mueckler M. Maternal hyperglycemia alters glucose transport and utilization in mouse preimplantation embryos. Am J Physiol 1998; 275:E38-E47.
24. Hogan A, Heyner S, Charron MJ, Copeland NG, Gilbert DJ, Jenkins MA, Thorens B, Schultz GA. Glucose transporter gene expression in early mouse embryos. Development 1991; 113:363-372.
25. Aghayan M, Rao LV, Smith RM, Jarett L, Charron MJ, Thorens B, Heyner S. Developmental expression and cellular localization of glucose transporter molecules during mouse preimplantation development. Development 1992; 115:305-312.
26. Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol 1998; 161:2833-2840.
27. Matsuzaki H, Schmied BM, Ulrich A, Standop J, Schneider MB, Batra SK, Picha KS, Pour PM. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and actinomycin D induces apoptosis even in TRAIL-resistant human pancreatic cancer cells. Clin Cancer Res 2001; 7:407-414.
28. Olsson A, Diaz T, Aguilar-Santelises M, Osterborg A, Celsing F, Jondal M, Osorio LM. Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D. Leukemia 2001; 15:1868-1877.
29. Zisman A, Ng CP, Pantuck AJ, Bonavida B, Belldegrun AS. Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosis. J Immunother 2001; 24:459-471.
30. Hernandez A, Wang QD, Schwartz SA, Evers BM. Sensitization of human colon cancer cells to TRAIL-mediated apoptosis. J Gastrointest Surg 2001; 5:56-65.
31. Generoso WM, Rutledge JC, Cain KT, Hughes LA, Braden PW. Exposure of female mice to ethylene oxide within hours after mating leads to fetal malformation and death. Mutat Res 1987; 176:269-274.
32. Greene MF, Hare JW, Cloherty JP, Benacerraf BR, Soeldner JS. First-trimester hemoglobin Al and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology 1989; 39:225-231.
33. Kimmel CA, Generoso WM, Thomas RD, Bakshi KS. A new frontier in understanding the mechanisms of developmental abnormalities. Toxicol Appl Pharmacol 1993; 119:159-165.
34. Hawthorne G, Robson S, Ryall EA, Sen D, Roberts SH, Ward Platt MP. Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994 [see comments]. BMJ 1997; 315:279-281.
35. Polifka JE, Rutledge JC, Kimmel GL, Dellarco V, Generoso WM. Exposure to ethylene oxide during the early zygotic period induces skeletal anomalies in mouse fetuses. Teratology 1996; 53:1-9.
36. Pregnancy outcomes in the Diabetes Control and Complications Trial [see comments]. Am J Obstet Gynecol 1996; 174:1343-1353.
37. Wuu YD, Pampfer S, Becquet P, Vanderheyden I, Lee KH, De Hertogh R. Tumor necrosis factor α decreases the viability of mouse blastocysts in vitro and in vivo. Biol Reprod 1999; 60:479-483.
38. Chi MM, Pingsterhaus J, Carayannopoulos M, Moley KH. Decreased glucose transporter expression triggers BAX-dependent apoptosis in the murine blastocyst. J Biol Chem 2000; 275:40252-40257.
39. Mohr LR, Trounson AO. Comparative ultrastructure of hatched human, mouse and bovine blastocysts. J Reprod Fertil 1982; 66:499-504.
40. Handyside A, Hunter S. Cell division and death in the mouse blastocyst before implantation. Roux's Arch Dev Biol 1986; 195:519-525.
41. Jurisicova A, Varmuza S, Casper RF. Involvement of programmed cell death in preimplantation embryo demise. Hum Reprod Update 1995; 1:558-566.
42. Jurisicova A, Varmuza S, Casper RF. Programmed cell death and human embryo fragmentation. Mol Hum Reprod 1996; 2:93-98.
43. Brison DR, Schultz RM. Apoptosis during mouse blastocyst formation: evidence for a role for survival factors including transforming growth factor α. Biol Reprod 1997; 56:1088-1096.
44. Jurisicova A, Latham KE, Casper RF, Varmuza SL. Expression and regulation of genes associated with cell death during murine preimplantation embryo development. Mol Reprod Dev 1998; 51:243-253.
45. Erenus M, Zouves C, Rajamahendran P, Leung S, Fluker M, Gomel V. The effect of embryo quality on subsequent pregnancy rates after in vitro fertilization. Fertil Steril 1991; 56:707-710.
46. Pierce GB, Lewellyn AL, Parchment RE. Mechanism of programmed cell death in the blastocyst. Proc Natl Acad Sci U S A 1989; 86: 3654-3658.
47. Mariani SM, Matiba B, Armandola EA, Krammer PH. Interleukin 1β-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J Cell Biol 1997; 137:221-229.
48. Mariani SM, Krammer PH. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage. Eur J Immunol 1998; 28:973-982.
49. Gura T. How TRAIL kills cancer cells, but not normal cells. Science 1997; 277:768.
50. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997; 277:815-818.
51. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997; 277:818-821.
52. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388:190-195.
53. Mongkolsapaya J, Cowper AE, Xu XN, Morris G, McMichael AJ, Bell JI, Screaton GR. Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL. J Immunol 1998; 160:3-6.
54. Leverkus M, Neumann M, Mengling T, Rauch CT, Brocker EB, Krammer PH, Walczak H. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res 2000; 60:553-559.
55. Walczak H, Krammer PH. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 2000; 256:58-66.
56. Ahmad M, Shi Y. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention. Oncogene 2000; 19:3363-3371.
57. Nesterov A, Ivashchenko Y, Kraft AS. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells. Oncogene 2002; 21:1135-1140.
58. Malhotra R, Lin Z, Vincenz C, Brosius FC III. Hypoxia induces apoptosis via two independent pathways in Jurkat cells: differential regulation by glucose. Am J Physiol 2001; 281: C1596-C1603.
59. Nam SY, Amoscato AA, Lee YJ. Low glucose-enhanced TRAIL cytotoxicity is mediated through the ceramide-Akt-FLIP pathway. Oncogene 2002; 21:337-346.
60. Kawamura K, Fukuda J, Kodama H, Kumagai J, Kumagai A, Tanaka T. Expression of Fas and Fas ligand mRNA in rat and human preimplantation embryos. Mol Hum Reprod 2001; 7:431-436.
61. Zou GM, Reznikoff-Etievant MF, Leon A, Verge V, Hirsch F, Milliez J. Fas-mediated apoptosis of mouse embryo stem cells: its role during embryonic development. Am J Reprod Immunol 2000; 43:240-248.
62. Bamberger AM, Schulte HM, Thuneke I, Erdmann I, Bamberger CM, Asa SL. Expression of the apoptosis-inducing Fas ligand (FasL) in human first- and third-trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab 1997; 82:3173-3175.
63. Galan A, O'Connor JE, Valbuena D, Herrer R, Remohi J, Pampfer S, Pellicer A, Simon C. The human blastocyst regulates endometrial epithelial apoptosis in embryonic adhesion. Biol Reprod 2000; 63:430-439.
64. Yelavarthi KK, Chen HL, Yang YP, Cowley BD Jr, Fishback JL, Hunt JS. Tumor necrosis factor α mRNA and protein in rat uterine and placental cells. J Immunol 1991; 146:3840-3848.
65. Pampfer S, Wuu YD, Vanderheyden I, De Hertogh R. Expression of tumor necrosis factor α (TNFα) receptors and selective effect of TNFα on the inner cell mass in mouse blastocysts. Endocrinology 1994; 134: 206-212.
66. Kohchi C, Tanabe Y, Noguchi K, Mizuno D, Soma G. Induction of differentiation in embryonic stem cells by 26-kD membrane-bound tumor necrosis factor (TNF) and 17-kD free TNF. In Vivo 1996; 10: 19-27.
67. Ben-Yair E, Less A, Lev S, Ben-Yehoshua L, Tartakovsky B. Tumor necrosis factor α binding to human and mouse trophoblast. Cytokine 1997; 9:830-836.
68. Wuu YD, Pampfer S, Vanderheyden I, Lee KH, De Hertogh R. Impact of tumor necrosis factor α on mouse embryonic stem cells. Biol Reprod 1998; 58:1416-1424.
69. Pampfer S, Moulaert B, Vanderheyden I, Wuu YD, De Hertogh R. Effect of tumor necrosis factor α on rat blastocyst growth and glucose metabolism. J Reprod Fertil 1994; 101:199-206.
70. Pampfer S, Vanderheyden I, Vesela J, De Hertogh R. Neutralization of tumor necrosis factor α (TNFα) action on cell proliferation in rat blastocysts by antisense oligodeoxyribonucleotides directed against TNFα p60 receptor. Biol Reprod 1995; 52:1316-1326.